Screener
Pulse Biosciences, Inc. PLSE Business Segments — Manufacturing Costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ManufacturingCosts.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenue | $434 | — | $835 | — |
| Adjusted cost of product revenue1 | 245 | — | 571 | — |
| Cross platform research and engineering2 | 6,078 | 4,585 | 11,258 | 8,535 |
| R&D manufacturing and engineering3 | 3,201 | 2,941 | 5,550 | 4,736 |
| Clinical and regulatory4 | 5,127 | 2,183 | 8,387 | 3,943 |
| General and administrative5 | 4,548 | 2,742 | 8,490 | 5,461 |
| Sales and marketing6 | 1,279 | 2,362 | 3,607 | 4,218 |
| Other segment items7 | 5,228 | 5,462 | 7,394 | 11,426 |
Document
FAQ
- What is Pulse Biosciences, Inc.'s business segments — manufacturing costs?
- Pulse Biosciences, Inc. (PLSE) reported business segments — manufacturing costs of $3.2M in Q2 2026.
- What does business segments — manufacturing costs mean?
- This represents the specific operational expenditures associated with the production, assembly, and quality control of medical devices. It provides insight into the scalability and efficiency of the company's manufacturing processes.
Ask your AI about Pulse Biosciences, Inc.'s business segments — manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude